VueBox® for quantitative analysis of contrast-enhanced ultrasound in liver tumors-Reference-Cited by-同舟云学术

VueBox® for quantitative analysis of contrast-enhanced ultrasound in liver tumors

Published:2021-12-05 Issue: Volume: Page:1-14
ISSN:1386-0291
Container-title:Clinical Hemorheology and Microcirculation
language:
Short-container-title:CH

Author:

Dong Yi¹,Koch Jonas B.H.²,Löwe Axel L.²,Christen Michael²,Wang Wen-Ping¹,Jung Ernst-Michael³,Mohaupt Markus G.⁴,Dietrich Christoph F.²

Affiliation:

1. Department of Ultrasound, Zhongshan Hospital, Fudan University, Shanghai, China

2. Department General Internal Medicine, Hirslanden Clinics Beau-Site, Salem and Permancence, Bern, Switzerland

3. Department of Radiology, University Medical Center Regensburg, Regensburg, Germany

4. Department of Medicine, Teaching Hospital General Medicine Lindenhofgruppe, Berne, Switzerland

Abstract

Dynamic contrast-enhanced ultrasound (DCE-US) enables quantification of tumor perfusion. VueBox is a platform independent external software using DICOM cine loops which objectively provides various DCE-US parameters of tumor vascularity. This review summaries its use for diagnosis and treatment monitoring of liver tumors. The existing literature provides evidence on the successful application of Vuebox based DCE-US for characterization and differential diagnosis of focal liver lesions, as well as on its use for monitoring of local ablative therapies and of modern systemic treatment in oncology.

Publisher

IOS Press

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine,Hematology,Physiology

Reference45 articles.

1. AASLD guidelines for the treatment of hepatocellular carcinoma;Heimbach;Hepatology,2018

2. Asia-Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a update;Omata;Hepatol Int,2017

3. Electronic address eee, European Association for the Study of the L. EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma;European Association for the Study of the Liver;J Hepatol,2018

4. Guidelines and Good Clinical Practice Recommendations for Contrast-Enhanced Ultrasound (CEUS) in the Liver-Update 2020 WFUMB in Cooperation with EFSUMB, AFSUMB, AIUM, and FLAUS;Dietrich;Ultrasound Med Biol,2020

5. EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma;European Association For The Study Of The L, European Organisation For R, Treatment Of C;J Hepatol,2012

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The value of contrast-enhanced ultrasound combined with microflow imaging in predicting microvascular invasion of hepatocellular carcinoma before operation;Clinical Hemorheology and Microcirculation;2024-09-05

2. Clinical application of dual-layer spectral CT multi-parameter feature to predict microvascular invasion in hepatocellular carcinoma;Clinical Hemorheology and Microcirculation;2024-09-05

3. Dynamic Contrast-Enhanced Ultrasonography Combined With LR-M Classification Criteria for Differentiating Malignant Liver Nodules at High Risk for Hepatocellular Carcinoma;Ultrasound in Medicine & Biology;2024-07

4. Application of dynamic contrast enhanced ultrasound analysis in predicting early response to systemic therapy of intrahepatic cholangiocarcinoma;European Journal of Radiology;2024-06

5. Contrast-enhanced ultrasound for the preoperative prediction of pathological characteristics in breast cancer;Frontiers in Oncology;2024-02-29